Reveal hidden market
Challenges and opportunities.
Drive brand performance.

Assess healthcare
product
opportunities

Understand the global
healthcare
market

Expand your
healthcare
product offering

Develop
a healthcare brand

Brand launch and
post-launch
marketing

Get to know us!

AplusA is one of the world’s leading independent market research agencies dedicated entirely to healthcare.

Areas of expertise

AplusA is founded by physicians, and a high level of expertise is at the core of everything we do.

Reveal hidden market
Challenges and opportunities.
Drive brand performance

Assess healthcare
product
opportunities

Understand the global
healthcare
market

Expand your
pharmaceutical
product offering

Develop
a healthcare brand

Brand launch and
post-launch
marketing

Get to know us !

AplusA is one of the world’s leading independent market research agencies dedicated entirely to healthcare.

Areas of expertise

AplusA is founded by physicians, and a high level of expertise is at the core of everything we do.

Latest resources

AplusA is an expert
in Hematology, Oncology and Immunology markets.

Using results from AplusA’s syndicated Hemophilia tracker discover the key benefits of a patient chart syndicated tracker, brand performance insights, patient insights, market dynamics and more.

You may also check all our E-books in our resource section

Hemophilia A&B eBook

Follow
us

2/2

3 waves are already available in our #syndicated #study!
Example of recent results:
- #Data collected up to June 28th, 2021
- From 254 Onco-Hematologists
- Across FR, DE, IT, ES, CA & SE
- 977 detailed #patient record forms
Get more #insights now 👇

LP / Syndicated Study / Beta-Thalassemia 2021

Syndicated Study - BETA-THAL

Learn from the most recent Beta-Thalassemia market data based on real-world patient data to support strategic decision making.

hubs.ly

1/2

🔎 #SyndicatedStudies | BETATHALsyndiTrack™
Beta Thalassemias are a group of inherited blood disorders caused by reduced/absent synthesis of the beta chains of #hemoglobin. This defect results in chronic #anemia & reduced patient's quality of life.

2/3

Examples of that are when results from our work get published such as this “Realités” survey conducted in France for a big #pharmacompany who trusted us to bring out the reality behind #BreastCancer patient experiences.

Load More...

APLUSA
around the world

COVID-19 Business Continuity Plan. AplusA remains 100% operational.

A message of thanks and support to AplusA healthcare professional study respondents